BioSpace News Archive

Proteintech, the benchmark in antibodies and proteins, announces the launch of over 500 antibodies directly conjugated with high-performance CoraLite®488 and CoraLite®594 dyes.

Allele Biotechnology and Pharmaceuticals, Inc. (President and CEO: Jiwu Wang, Ph.D., “Allele”), a San Diego-based private company, and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”), through its Massachusetts-based subsidiary Astellas Institute for Regenerative Medicine (AIRM), entered into a licensing agreement to expand Astellas’ access to Allele’s induced pluripotent stem cell (iPSC) technologies for various cell therapy programs.

In a study involving nearly 10,000 adolescents, researchers reveal a relationship between lead exposure risk and brain structure in lower-income families

Cortica Inc. (“Cortica”), a leading provider of advanced neurological therapies for children with autism and other neurodevelopmental conditions, announced today leadership appointments to further its mission to design and deliver life-changing care – one child, one family, one community at a time.

Drug company Hoffmann-La Roche (OTCMKTS: RHHBY) bilked U.S. federal and state governments out of $1.5 billion by misrepresenting clinical studies and falsely claiming that its well-known influenza medicine Tamiflu was effective at containing potential pandemics, according to a recently unsealed whistleblower lawsuit.

Surgeons at Northwestern Medicine Urogynecology and Reconstructive Pelvic Surgery were recently the first in Illinois to implant a new type of sacral neuromodulator, a small device surgically placed in the pelvic area that restores nerve signals communicating between the brain, bladder and bowel.

Apellis Pharmaceuticals, Inc. (Nasdaq:APLS), a global biopharmaceutical company pioneering targeted C3 therapies, today announced the closing of its previously announced underwritten public offering of common stock, including the exercise in full by the underwriters of their option to purchase an additional 1,425,000 shares at the public offering price of $37.00 per share.

Bigfoot Biomedical, Inc. announced today that the company has raised $45 million in the initial tranche of a Series C equity financing.

Ginkgo Bioworks, the organism company, today announced that Jason Kelly, Ginkgo Bioworks CEO and co-founder, will present at the 38th Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2020 at 9:30 AM Pacific Time at the Westin St. Francis Hotel in San Francisco, room Elizabethan D.

SonoSim announces the launch of its SonoSim LiveScan® Neonatal & Infant Neurosonography Package, the first in a series of pediatric ultrasound training products